Skip to content

RESEARCH SYNTHESIS

What the research says about vibroacoustic therapy

This page synthesizes the clinical and mechanistic literature on vibroacoustic therapy. References are to peer-reviewed journal articles, systematic reviews, and pilot randomized trials. Evidence strength is labeled Strong, Moderate, or Weak based on study design, sample size, replication, and methodological quality, using a simple in-house rubric. Full references appear at the end of the page and are reproduced in Section 14 of the site's master design document. Last updated: April 2026.

Pain and fibromyalgia

Strong Evidence: Strong for chronic musculoskeletal pain at 40 Hz

The single largest body of VAT literature is on pain. A scoping review by Kantor et al. (2022) in BMJ Open examined vibroacoustic therapy in adults experiencing pain and found consistent reductions in visual analog scale (VAS) pain scores across multiple study designs, with the majority of protocols using sinusoidal low-frequency stimulation centered around 40 Hz for twenty to forty-five minute sessions (Kantor et al., 2022).

Campbell, Hynynen, Burger, and Ala-Ruona (2019) reported on a multidisciplinary vibroacoustic treatment program for chronic pain and comorbid mood disorders in a specialized Finnish healthcare setting, using a mixed-methods design. Patients reported decreased pain intensity, improved ability to work, and reduced psychological distress over the course of treatment. A second Campbell et al. (2019) paper extended the work into functional-outcome and return-to-work measures.

For fibromyalgia and chronic musculoskeletal pain, Eshuis et al. (2021) conducted a pilot study of music and low-frequency vibration in elderly patients and found meaningful reductions in pain and improvements in perceived wellbeing. In pediatric musculoskeletal pain, a small series reported positive results using frequencies up to 115 Hz, with larger adult studies consistently centering on 40 Hz (Ailioaie, Giménez, & Huaranga, 2020).

The open question: most pain studies are small, single-site, and unblinded. Large multi-center randomized controlled trials comparing VAT against active sham do not yet exist. The signal is real. The standardization is not.

Parkinson's disease and tremor

Moderate Evidence: Moderate

The most-cited Parkinson's VAT study is Mosabbir, Almeida, and Ahonen (2020), a double-blinded randomized controlled trial of long-term 40 Hz physioacoustic vibration on motor impairments in Parkinson's disease. Published in Healthcare, it reported significant improvements in motor symptoms over twelve weeks of treatment compared to control.

An earlier narrative review by Leuk, Low, and Teo (2020) on acoustic-based interventions for Parkinson's catalogued the emerging rationale: rhythmic low-frequency input may entrain basal ganglia and thalamo-cortical networks whose oscillations are disrupted in Parkinsonian states. A 2023 physical medicine report on VAT in Parkinsonian patients as a complementary rehabilitation approach reinforced the signal but emphasized that trial sizes remain small (C. et al., 2023).

A reasonable reading of the Parkinson's literature: 40 Hz, applied repeatedly over several weeks, shows clinically meaningful short-term motor gains in early- and mid-stage Parkinson's patients in small trials. It has not been compared against standard rehabilitation in a large pragmatic study. It should not be substituted for conventional care. It is a plausible adjunct.

Anxiety, stress, and relaxation

Moderate to Strong Evidence: Moderate to Strong

The stress and anxiety literature is one of the most consistent in VAT. Nair and Kethar (2022) examined the effectiveness of VAT in alleviating stress and found measurable reductions in self-reported stress after brief sessions. Fooks and Niebuhr (2024), publishing in Sensors, examined vibroacoustic stimulation against psychological, physiological, and cognitive stress markers, with positive results across multiple modalities of measurement including heart rate variability.

Campbell et al. (2019), in the mixed-methods study cited under Pain above, documented reductions in depression and anxiety comorbid with chronic pain. Several clinical programs (detailed on the Find a Provider page) explicitly use VAT for nervous-system downregulation before or after ketamine-assisted therapy, and some addiction recovery programs document a parasympathetic shift within approximately twenty-two minutes of session time (see the St. John's Recovery Place disclosure in the provider directory).

The mechanism most commonly proposed: parasympathetic activation through vagal afferent stimulation and through direct modulation of Pacinian-corpuscle-mediated sensory input (Bartel & Mosabbir, 2021). The outcomes are reproducible. The mechanism is plausible. The frequency of choice remains around 40 Hz.

Autism and sensory processing

Weak to Moderate Evidence: Weak to Moderate. Promising but early.

Vibroacoustic and related sensory-integration therapies have a long clinical history in autism and sensory processing differences, but the peer-reviewed evidence base is smaller and less methodologically rigorous than the pain or anxiety literature. Much of the published work is case-report, single-subject design, or observational.

The clinical rationale is straightforward: many autistic individuals experience hyper- or hypo-responsivity to sensory input, and low-frequency whole-body vibration appears, in practice, to reduce arousal and improve self-regulation in a subset of individuals. Skille himself worked heavily with pediatric populations, including autistic children, when developing VAT. The modality is used in special education and occupational therapy settings worldwide.

The honest reading: the lived-experience and clinical-case evidence is substantial, and the parasympathetic-activation mechanism has face validity for sensory regulation. The controlled-trial evidence is thin. VAT should not be presented as a treatment for autism. It can reasonably be presented as a regulation-support tool, used within a broader occupational-therapy or integrative framework, with family and provider oversight.

Cerebral palsy and developmental motor work

Moderate Evidence: Moderate

Kantor, Kantorová, Mareckova, Peng, and Vilímek (2019) published an advanced narrative review on the potential of vibroacoustic therapy in persons with cerebral palsy in the International Journal of Environmental Research and Public Health. The review synthesized multiple small studies and clinical protocols and concluded that VAT is a plausible adjunct for spasticity reduction, with effects most consistently demonstrated at low frequencies (20 to 40 Hz) applied repeatedly over several weeks.

Adaikina, Derraik, Hofman, and Gusso (2023) conducted a randomized controlled study in young children with mild to moderate cerebral palsy and compared 20 Hz to 25 Hz protocols. Both frequencies produced comparable improvements in gross motor function, and the authors concluded that treatment duration may matter more than fine-grained frequency choice within this range.

Ritzmann, Stark, and Krause (2018), in a systematic review of vibration therapy in cerebral palsy, found consistent but modest improvements in spasticity and motor function across included studies.

A reasonable clinical summary: VAT, especially at low frequencies applied over weeks to months, is a defensible adjunct in pediatric cerebral palsy programs, typically alongside physical therapy rather than in place of it.

Stroke and motor recovery

Moderate to Strong Evidence: Moderate to Strong (focal), Moderate (whole-body)

Post-stroke motor recovery is where the vibration-therapy literature is strongest and most rigorously reviewed, though much of it concerns focal muscle vibration rather than full-body VAT. Zeng et al. (2023) published a systematic review and meta-analysis of vibration therapy for post-stroke spasticity in BioMedical Engineering OnLine and reported significant reductions in spasticity and improvements in upper-limb function.

Lu et al. (2024) in the Journal of NeuroEngineering and Rehabilitation performed a systematic review and meta-analysis of vibration therapy for upper extremity function and disability recovery after stroke and found clinically meaningful gains. Giorgi, Donati, Platano, and Tedeschi (2024) reviewed focal vibration therapy for motor deficits and spasticity management in post-stroke rehabilitation in Brain Sciences and reported consistent benefit when vibration is combined with active rehabilitation.

Calabrò et al. (2017), in a pilot randomized controlled trial published in PLoS ONE, combined muscle vibration with robotic rehabilitation and demonstrated that the combination outperformed either alone, consistent with an associative-plasticity model.

Seo, Kim, and Seok (2025) published a systematic review and meta-analysis of whole-body vibration on stroke spasticity, again showing favorable effect sizes. A separate 2025 Seo et al. review looked at vibration therapy's effects on activities of daily living after stroke, with positive results at session counts of approximately 13 to 24.

Summary: vibration therapy for post-stroke motor recovery is among the most evidence-supported applications in the broader vibration literature, with full-body VAT as an adjacent and reasonably supported subset.

Respiratory applications

Moderate Evidence: Moderate

A recent and underappreciated line of VAT research comes from Kazakhstan. Konkayev and Bekniyazova (2023) published a pilot randomized controlled trial in Frontiers in Medicine of vibroacoustic therapy in COVID-19 patients complicated by respiratory failure, and reported improved oxygenation parameters and reduced hospital stay in the VAT-treated group. Bekniyazova et al. (2022) had earlier published a case report on complex treatment using VAT in a patient with co-infection and COVID-19. Konkayev, Bekniyazova, Khamidullina, and Konkayeva (2024) followed with a case series on vibroacoustic pulmonary therapy in thoracic trauma complicated by acute respiratory failure.

In pediatrics, Syzdykova, Morenko, Gatauova, Zhumambayeva, and Shnaider (2023) reported on the efficacy of vibroacoustic therapy in treatment of pneumonia in children with bronchopulmonary dysplasia in the Russian Open Medical Journal.

The proposed mechanism is mechanical: low-frequency vibration delivered through the chest wall may assist mucociliary clearance and alveolar recruitment. This is conceptually close to what the respiratory therapy field calls high-frequency chest wall oscillation, though delivered at different amplitude and frequency.

The respiratory VAT literature is early but encouraging. It has not yet entered mainstream pulmonology guidelines.

Cognitive function in older adults

Moderate Evidence: Moderate

Bae et al. (2025), in Frontiers in Aging Neuroscience, published a double-blind, randomized, comparative trial of transcranial vibroacoustic stimulation for neuropsychological and cognitive functions in older adults. The study reported significant improvement in multiple cognitive domains and changes in EEG and event-related potential markers consistent with enhanced neural plasticity. The frequency of choice was 40 Hz, consistent with an emerging broader literature on 40 Hz stimulation for gamma-band cognitive effects.

Bartel, Chen, Alain, and Ross (2017), in Music and Medicine, tied the mechanistic rationale to brain oscillation research: 40 Hz vibroacoustic stimulation may support the kind of gamma-band entrainment that is being studied in Alzheimer's disease and age-related cognitive decline by other research teams using non-invasive light and sound stimulation.

The VAT cognitive literature is smaller than the broader 40 Hz sensory-stimulation literature, and should be read as complementary rather than independent.

Comparison to related modalities

This section helps a reader who has heard of adjacent modalities understand where VAT sits.

Tuning fork therapy

Weighted tuning forks (often 128 Hz, 256 Hz, or other tuned frequencies) are used in craniosacral, osteopathic, and energy-work contexts for focal vibration applied to acupressure points, joints, or the cranium. They deliver higher-frequency, lower-amplitude, brief-duration vibration compared to VAT. The peer-reviewed evidence base is thinner, and mechanistic rationale is less developed. Tuning fork work overlaps in spirit but not in parameters.

Therapeutic ultrasound

Medical ultrasound used in physical therapy operates at 1 to 3 MHz, orders of magnitude higher than VAT. It produces deep tissue heating and micro-mechanical effects and is regulated as a medical device. VAT operates in the 20 to 200 Hz range, is felt consciously as vibration, and does not produce ultrasound-scale tissue heating.

Whole-body vibration (WBV)

WBV platforms used in athletic training and rehabilitation operate at roughly 20 to 50 Hz with much larger mechanical amplitudes than VAT, and the body moves with the platform. VAT uses smaller amplitude vibration delivered through the body's contact surfaces rather than whole-platform oscillation. The two literatures overlap substantially, and some systematic reviews (for example, Petrigna et al., 2024; Bonanni et al., 2022) draw on both. Clinically, WBV is more intense and more fatiguing; VAT is passive and relaxation-compatible.

Binaural beats and solfeggio tones

These are audio-only interventions delivered through headphones and make claims about frequency-specific brain entrainment. They do not deliver mechanical vibration to the body. Some cross-over exists in consumer marketing, and the site treats these as distinct from VAT.

Sound baths

Sound baths use gongs, singing bowls, and other acoustic instruments to flood a room with complex harmonic content. They overlap with VAT in subjective experience but not in parameters; most sound-bath frequencies are above the VAT therapeutic band and are not transducer-coupled to the body.

Mechanisms under investigation

Nine proposed mechanisms, each with a supporting citation:

  1. Pacinian corpuscle activation and sensory gating (Bartel & Mosabbir, 2021)
  2. Spinal reflex modulation via Ia afferent input, H-reflex suppression, presynaptic inhibition (Zeng et al., 2023; Avvantaggiato et al., 2020)
  3. Gamma-band cortical entrainment at 40 Hz (Bartel et al., 2017; Bae et al., 2025)
  4. Parasympathetic activation via vagal afferent signaling (Bartel & Mosabbir, 2021)
  5. Spinal gate-control analgesia (Casale & Hansson, 2022)
  6. Cortical excitability changes (increased SICI, modified MEP amplitude) (Giorgi et al., 2024; Toscano et al., 2020)
  7. Basal ganglia and thalamo-cortical network modulation in Parkinson's (Leuk et al., 2020)
  8. Neurotransmitter rebalancing (GABA / glutamate) proposed by Calderone et al. (2025)
  9. Mechanical assistance to mucociliary clearance in respiratory applications (Konkayev & Bekniyazova, 2023)

Gaps in the evidence

The VAT evidence base has real strengths (pain, stress, stroke-related spasticity) and real weaknesses. The most consistent gaps:

  • Large multi-center randomized controlled trials are essentially absent across every indication. Most positive findings come from small single-site studies.
  • Device-to-device comparisons are rare. A frequency of 40 Hz delivered through a Somatron bed, an inHarmony lounge, and a custom-built DIY table is not necessarily the same experience.
  • Active sham controls are methodologically difficult. Patients can feel whether a device is vibrating.
  • Pediatric and pregnancy data are limited by design, ethical concerns, and caution.
  • Long-term follow-up is almost non-existent. Whether VAT gains are durable remains largely unstudied.
  • Autism-specific controlled trials are few.

Claims should be sized accordingly. Anyone selling VAT as a cure for any specific disease is selling something the literature does not support.

If you have a pacemaker, ICD, cochlear implant, deep brain stimulator, vagus nerve stimulator, or spinal cord stimulator… do not receive vibroacoustic therapy without explicit clearance from the device manufacturer and your treating physician. See Safety and Contraindications for more.

Frequencies and protocols at a glance

Indication Typical frequency Typical session Total course Evidence
Chronic musculoskeletal pain 40 Hz 20–45 min Daily to weekly, ongoing Strong
Post-stroke spasticity / motor 30–80 Hz focal or whole-body 20–30 min 13–24 sessions Strong (focal)
Parkinson's motor symptoms 40 Hz 30 min ≥ 12 weeks Moderate
Anxiety / stress / HRV 40 Hz 20–30 min Single or repeated Moderate to Strong
Cerebral palsy (pediatric) 20–25 Hz 9–20 min 12–20 weeks Moderate
Cognitive function (older adults, transcranial) 40 Hz 20–30 min Multiple weeks Moderate
Respiratory (COVID-19, BPD) Device-specific, low band Per protocol Inpatient adjunct Moderate
Post-exercise vigor recovery 52 Hz 15–30 min Per session Weak to Moderate

These are typical parameters drawn from the cited literature. They are not personalized clinical prescriptions. A qualified provider individualizes the protocol to the patient.

References

  1. Adaikina, A., Derraik, J., Hofman, P., & Gusso, S. (2023). Vibration therapy in young children with mild to moderate cerebral palsy: does frequency and treatment duration matter? A randomised-controlled study. BMC Pediatrics, 23. https://doi.org/10.1186/s12887-022-03786-1
  2. Ailioaie, A., Giménez, R., & Huaranga, R. (2020). FRI0639-HPR Effects of vibroacoustic therapy in chronic musculoskeletal pain in children and adolescents. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-eular.6290
  3. Ali, M., Akhtar, H., Ghumman, U., & Haseeb, M. (2025). Vibroacoustic therapy in neurorehabilitation: emerging potential and gaps. The Rehabilitation Journal. https://doi.org/10.52567/trehabj.v9i04.111
  4. Avvantaggiato, C., Casale, R., Cinone, N., Facciorusso, S., Turitto, A., Stuppiello, L., Picelli, A., Ranieri, M., Intiso, D., Fiore, P., Ciritella, C., & Santamato, A. (2020). Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review. European Journal of Physical and Rehabilitation Medicine. https://doi.org/10.23736/s1973-9087.20.06390-x
  5. Bae, J., Ha, J., Choung, J., Cho, M., Oh, B., Lee, K., Youn, Y., Kim, S., Song, D., & Shin, C. (2025). Improvement of neuropsychological and cognitive functions in older adults through transcranial vibroacoustic stimulation: a double blind, randomized, comparative trial. Frontiers in Aging Neuroscience, 17. https://doi.org/10.3389/fnagi.2025.1526088
  6. Bartel, L., & Mosabbir, A. (2021). Possible mechanisms for the effects of sound vibration on human health. Healthcare, 9. https://doi.org/10.3390/healthcare9050597
  7. Bartel, L., Chen, R., Alain, C., & Ross, B. (2017). Vibroacoustic stimulation and brain oscillation: from basic research to clinical application. Music and Medicine, 9, 153–166. https://doi.org/10.47513/mmd.v9i3.542
  8. Bekniyazova, A., Kadralinova, A., Konkayeva, M., Yeltayeva, A., & Konkayev, A. (2022). Case report: complex treatment using vibroacoustic therapy in a patient with co-infection and COVID-19. Frontiers in Medicine, 9. https://doi.org/10.3389/fmed.2022.893306
  9. Bonanni, R., Cariati, I., Romagnoli, C., D'Arcangelo, G., Annino, G., & Tancredi, V. (2022). Whole body vibration: a valid alternative strategy to exercise? Journal of Functional Morphology and Kinesiology, 7. https://doi.org/10.3390/jfmk7040099
  10. C., D., R, D., G, G., G, S., & P, B. (2023). Vibroacoustic therapy in Parkinsonian patients: a complementary approach to improve rehabilitation outcome. Physical Medicine and Rehabilitation International. https://doi.org/10.26420/physmedrehabilint.2023.1208
  11. Calabrò, R., Naro, A., Russo, M., Milardi, D., Leo, A., Filoni, S., Trinchera, A., & Bramanti, P. (2017). Is two better than one? Muscle vibration plus robotic rehabilitation to improve upper limb spasticity and function: a pilot randomized controlled trial. PLoS ONE, 12. https://doi.org/10.1371/journal.pone.0185936
  12. Calderone, A., Galasso, S., De Nunzio, A., Leo, A., Balletta, T., Quartarone, A., & Calabrò, R. (2025). Exploring the impact of muscle vibration therapy in neurologic rehabilitation: a systematic review. Archives of Rehabilitation Research and Clinical Translation, 7. https://doi.org/10.1016/j.arrct.2025.100478
  13. Campbell, E., Hynynen, J., & Ala-Ruona, E. (2017). Vibroacoustic treatment for chronic pain and mood disorders in a specialized healthcare setting. Music and Medicine, 9, 187–197. https://doi.org/10.47513/mmd.v9i3.540
  14. Campbell, E., Hynynen, J., Burger, B., & Ala-Ruona, E. (2019). Exploring the use of vibroacoustic treatment for managing chronic pain and comorbid mood disorders: a mixed methods study. Nordic Journal of Music Therapy, 28, 291–314. https://doi.org/10.1080/08098131.2019.1604565
  15. Campbell, E., Hynynen, J., Burger, B., Vainionpää, A., & Ala-Ruona, E. (2019). Vibroacoustic treatment to improve functioning and ability to work: a multidisciplinary approach to chronic pain rehabilitation. Disability and Rehabilitation, 43, 2055–2070. https://doi.org/10.1080/09638288.2019.1687763
  16. Campbell, E., Kantor, J., Kantorová, L., Svobodová, Z., & Wosch, T. (2022). Tactile low frequency vibration in dementia management: a scoping review. Frontiers in Psychology, 13. https://doi.org/10.3389/fpsyg.2022.854794
  17. Casale, R., & Hansson, P. (2022). A narrative review on the analgesic effect of localised vibration, part 1: the neurophysiological basis. European Journal of Physical and Rehabilitation Medicine. https://doi.org/10.23736/s1973-9087.22.07415-9
  18. Eshuis, T., Stuijt, P., Timmerman, H., Nielsen, P., Wolff, A., & Soer, R. (2021). Music and low-frequency vibrations for the treatment of chronic musculoskeletal pain in elderly: a pilot study. PLoS ONE, 16. https://doi.org/10.1371/journal.pone.0259394
  19. Fattorini, L., Pettorossi, V., Marchetti, E., Rodio, A., & Filippi, G. (2025). A review about muscle focal vibration contribution on spasticity recovery. Frontiers in Neurology, 16. https://doi.org/10.3389/fneur.2025.1579118
  20. Fooks, C., & Niebuhr, O. (2024). Effects of vibroacoustic stimulation on psychological, physiological, and cognitive stress. Sensors (Basel, Switzerland), 24. https://doi.org/10.3390/s24185924
  21. Giorgi, F., Donati, D., Platano, D., & Tedeschi, R. (2024). Focal vibration therapy for motor deficits and spasticity management in post-stroke rehabilitation. Brain Sciences, 14. https://doi.org/10.3390/brainsci14111060
  22. Kantor, J., Campbell, E., Kantorová, L., Mareckova, J., Regec, V., Karasová, K., Sedláčková, D., & Klugar, M. (2022). Exploring vibroacoustic therapy in adults experiencing pain: a scoping review. BMJ Open, 12. https://doi.org/10.1136/bmjopen-2020-046591
  23. Kantor, J., Kantorová, L., Mareckova, J., Peng, D., & Vilímek, Z. (2019). Potential of vibroacoustic therapy in persons with cerebral palsy: an advanced narrative review. International Journal of Environmental Research and Public Health, 16. https://doi.org/10.3390/ijerph16203940
  24. Kitsantas, P., Mejia, M., Seewak, R., Sacca, L., & Hennekens, C. (2024). Vibroacoustic therapy to treat pain in the temporomandibular joint. Medical Hypotheses. https://doi.org/10.1016/j.mehy.2024.111321
  25. Konkayev, A., & Bekniyazova, A. (2023). Vibroacoustic therapy in the treatment of patients with COVID-19 complicated by respiratory failure: a pilot randomized controlled trial. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1225384
  26. Konkayev, A., Bekniyazova, A., Khamidullina, Z., & Konkayeva, M. (2024). Case series report: use of vibroacoustic pulmonary therapy in patients with thoracic trauma complicated by acute respiratory failure. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1399397
  27. Leuk, J., Low, L., & Teo, W. (2020). An overview of acoustic-based interventions to improve motor symptoms in Parkinson's disease. Frontiers in Aging Neuroscience, 12. https://doi.org/10.3389/fnagi.2020.00243
  28. Lim, E., Lim, R., Suhaimi, A., Chan, B., & Wahab, A. (2018). Treatment of chronic back pain using indirect vibroacoustic therapy: a pilot study. Journal of Back and Musculoskeletal Rehabilitation, 31, 1041–1047. https://doi.org/10.3233/bmr-171042
  29. Lu, Y., Chen, H., Liao, C., Chen, P., Wang, X., Yu, C., Chen, P., & Lin, C. (2024). Upper extremity function and disability recovery with vibration therapy after stroke: a systematic review and meta-analysis of RCTs. Journal of NeuroEngineering and Rehabilitation, 21. https://doi.org/10.1186/s12984-024-01515-6
  30. Mammadov, I., Sahman, M., & Fazli, M. (2025). Effects of vibration and local vibration therapy. Turkish Journal of Clinical Research. https://doi.org/10.63909/1453004
  31. Manzo, N., Celletti, C., Conte, A., & Camerota, F. (2022). Comment to paper by Moggio et al. "Vibration therapy role in neurological diseases rehabilitation: an umbrella review of systematic reviews." Disability and Rehabilitation, 44, 4947–4948. https://doi.org/10.1080/09638288.2022.2030810
  32. Moggio, L., De Sire, A., Marotta, N., Demeco, A., & Ammendolia, A. (2021). Vibration therapy role in neurological diseases rehabilitation: an umbrella review of systematic reviews. Disability and Rehabilitation, 44, 5741–5749. https://doi.org/10.1080/09638288.2021.1946175
  33. Mosabbir, A., Almeida, Q., & Ahonen, H. (2020). The effects of long-term 40-Hz physioacoustic vibrations on motor impairments in Parkinson's disease: a double-blinded randomized control trial. Healthcare, 8. https://doi.org/10.3390/healthcare8020113
  34. Murillo, N., Valls-Solé, J., Vidal, J., Opisso, E., Medina, J., & Kumru, H. (2014). Focal vibration in neurorehabilitation. European Journal of Physical and Rehabilitation Medicine, 50(2), 231–242.
  35. Nair, V., & Kethar, J. (2022). The effectiveness of VAT in alleviating stress. Journal of Student Research. https://doi.org/10.47611/jsrhs.v11i4.3353
  36. Pałka, T., Maciejczyk, M., Czerwińska-Ledwig, O., Tota, Ł., Bawelski, M., Leiva-Arcas, A., Stabrawa, R., Bujas, P., Mucha, D., Wiśniewski, A., & Piotrowska, A. (2023). Effects of vibrotherapy with different characteristics and body position on post-exercise recovery after anaerobic exercise. Journal of Clinical Medicine, 12. https://doi.org/10.3390/jcm12144629
  37. Petrigna, L., Amato, A., Sortino, M., Trovato, B., Zanghì, M., Roggio, F., & Musumeci, G. (2024). Intervention hypothesis for training with whole-body vibration to improve physical fitness levels: an umbrella review. Journal of Functional Morphology and Kinesiology, 9. https://doi.org/10.3390/jfmk9020100
  38. Punkanen, M., & Ala-Ruona, E. (2012). Contemporary vibroacoustic therapy: perspectives on clinical practice, research, and training. Music and Medicine, 4, 128–135. https://doi.org/10.1177/1943862112445324
  39. Ritzmann, R., Stark, C., & Krause, A. (2018). Vibration therapy in patients with cerebral palsy: a systematic review. Neuropsychiatric Disease and Treatment, 14, 1607–1625. https://doi.org/10.2147/ndt.s152543
  40. Rüütel, E., Vinkel, I., & Eelmäe, P. (2017). The effects of short-term vibroacoustic treatment on spasticity and perceived health conditions of patients with spinal cord and brain injuries. Music and Medicine, 9, 202–208. https://doi.org/10.47513/mmd.v9i3.541
  41. Rüütel, E., Vinkel, I., & Laanetu, M. (2018). Vibroacoustic therapy and development of a new device: a pilot study in the health resort environment. Universal Journal of Public Health. https://doi.org/10.13189/ujph.2018.060502
  42. Seo, J., Kim, J., & Seok, J. (2025). The effects of whole-body vibration on spasticity in stroke: a systematic review and meta-analysis. Journal of Clinical Medicine, 14. https://doi.org/10.3390/jcm14175966
  43. Seo, J., Kim, J., Kim, J., & Seok, J. (2025). The effects of vibration therapy on activities of daily living after stroke: a systematic review and meta-analysis. Journal of Clinical Medicine, 14. https://doi.org/10.3390/jcm14217682
  44. Shah, V. (2021). A comprehensive critique of vibroacoustic therapy for physical and mental ailments.
  45. Syzdykova, M., Morenko, M., Gatauova, M., Zhumambayeva, S., & Shnaider, K. (2023). Efficacy of vibroacoustic therapy in treatment of pneumonia in children with bronchopulmonary dysplasia. Russian Open Medical Journal. https://doi.org/10.15275/rusomj.2023.0307
  46. Toscano, M., Ricci, M., Celletti, C., Paoloni, M., Ruggiero, M., Viganò, A., Jannini, T., Altarocca, A., Liberatore, M., Camerota, F., & Di Piero, V. (2020). Motor recovery after stroke: from a Vespa scooter ride over the Roman sampietrini to focal muscle vibration (fMV) treatment. A 99mTc-HMPAO SPECT and neurophysiological case study. Frontiers in Neurology, 11. https://doi.org/10.3389/fneur.2020.567833
  47. Wrześniewski, K., Pałka, T., & Blecharz, J. (2024). The influence of vibratory massage after physical exertion on selected psychological processes. Frontiers in Psychology, 15. https://doi.org/10.3389/fpsyg.2024.1380282
  48. Zeng, D., Lei, W., Kong, Y., Zhao, K., Ye, X., & Tan, T. (2023). Effects of vibration therapy for post-stroke spasticity: a systematic review and meta-analysis of randomized controlled trials. BioMedical Engineering OnLine, 22. https://doi.org/10.1186/s12938-023-01176-x
  49. Zhang, Q., Zheng, S., Li, S., Zeng, Y., Chen, L., Li, G., Li, S., He, L., Chen, S., Zheng, X., Zou, J., & Zeng, Q. (2023). Efficacy and safety of whole-body vibration therapy for post-stroke spasticity: a systematic review and meta-analysis. Frontiers in Neurology, 14. https://doi.org/10.3389/fneur.2023.1074922